[Amantadine and dexetimide in the treatment of parkinsonism].
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000547:Amantadine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001593:Benzyl Compounds / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003692:Delayed-Action Preparations; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy*; D010880:Piperidines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D001593:Benzyl Compounds; D003692:Delayed-Action Preparations; D010880:Piperidines; D000547:Amantadine
Amantadiini ja deksetimidi parkinsonismin hoidossa.